Anzeige
Mehr »
Donnerstag, 21.05.2026 - Börsentäglich über 12.000 News
Bewertet mit 8$ - Preis:139$: Peer-Übernahmen brachten Anlegern dreistellige Gewinne
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
GlobeNewswire (Europe)
577 Leser
Artikel bewerten:
(2)

FUJIFILM Holdings America Corporation: Fujifilm Partners with Tiger Health Technology to Enhance Digital Pathology Storage and Access

Lexington, MA, and Las Vegas, NV, March 03, 2025, a leading provider of enterprise imaging and informatics solutions, today announced a new strategic partnership with Tiger Health Technology, a leading provider of hybrid cloud solutions, to optimize data lifecycle management and address key storage-related challenges in digital pathology.

This technology integration will streamline the management and accessibility of digital pathology data managed through Synapse® Pathology, Fujifilm's picture archiving and communication system), addressing potential challenges with proprietary file format integrations.

"Our partnership with Tiger Health Technology will empower our customers to effectively manage large whole slide images. This can have a significant and positive impact on the cost of digital pathology file storage without degrading or delaying the clinical utility of these images," said Dr. Mark Lloyd, vice president, pathology, FUJIFILM Healthcare Americas Corporation. "Together, we are committed to providing rapid access to pathology information so patients can receive a rapid and accurate diagnosis."

"Digital health platforms offer promising solutions to key challenges in healthcare systems worldwide, particularly regarding costs, productivity, and accessibility," said Nikola Apostolov, chief executive officer, Tiger Health Technology. "We share Fujifilm's vision, and our partnership is a natural fit. Collaboration is the key to building sustainable healthcare platforms."

Fujifilm and Tiger Health Technology also plan to collaborate to develop innovative new solutions aimed at facilitating the wider adoption of digital pathology across healthcare systems. These solutions are intended to help resolve challenges related to the efficient storage and retrieval of medical data, while also improving overall data availability for more accurate, efficient, and scalable options for diagnosis and treatment planning.

Connect with representatives from Fujifilm and Tiger Health Technologies and demo Synapse Pathology at the following two upcoming conferences:

  • HIMSS (Healthcare Information and Management Systems Society) 2025 booth #1343, held March 4-6 at The Venetian Convention & Expo Center - learn more here (https://fujifilm-healthcare-americas.foleon.com/mi/fujifilm-at-himss/).
  • USCAP (United States and Canadian Academy of Pathology) booth 815, held March 24-26 at the Boston Convention and Exhibition Center - learn more here (https://fujifilm-healthcare-americas.foleon.com/mi/fujifilm-at-uscap-2025/).

About Fujifilm

FUJIFILM Healthcare Americas Corporation is a comprehensive healthcare company that has an extensive range of technology and expertise in the detection, diagnosis, and treatment of diseases. Fujifilm's innovative portfolio includes solutions spanning diagnostic imaging, enterprise imaging, endoscopic imaging, surgical imaging, and in-vitro diagnostics. The company is headquartered in Lexington, Massachusetts. For more information, please visit healthcaresolutions-us.fujifilm.com.

FUJIFILM Holdings Corporation, headquartered in Tokyo, leverages its depth of knowledge and proprietary core technologies to deliver innovative products and services across the globe through the four key business segments of healthcare, electronics, business innovation, and imaging with over 70,000 employees. Guided and united by our Group Purpose of "giving our world more smiles," we address social challenges and create a positive impact on society through our products, services, and business operations. Under its medium-term management plan, VISION2030, which ends in FY2030, we aspire to continue our evolution into a company that creates value and smiles for various stakeholders as a collection of global leading businesses and achieve a global revenue of 4 trillion yen. For more information, please visit: www.fujifilmholdings.com.

For further details about our commitment to sustainability and Fujifilm's Sustainable Value Plan 2030, click here.

About Tiger Health Technology .

Tiger Health Technology is a company of Tiger Technology, an experienced technology provider with 20 years of expertise in addressing mission-critical storage challenges across various industries on five continents. Its core specialization is healthcare data lifecycle management, and the primary focus is digital pathology. Leveraging the profound expertise and track record of Tiger Technology, the company is well-positioned to provide proven solutions that align with the evolving strategic trends in healthcare. For more information visit www.tiger-health.tech.


© 2025 GlobeNewswire (Europe)
Vergessen Sie Gold, Silber und Öl: Nächste Megarallye startet!
Die Märkte feiern neue Rekorde – doch im Hintergrund braut sich eine Entwicklung zusammen, die alles verändern könnte. Die anhaltende Sperrung der Straße von Hormus sorgt laut IEA für eine der größten Energiekrisen aller Zeiten. Gleichzeitig schießen die Preise für Düngemittel und Agrarrohstoffe bereits nach oben.

Damit droht ein perfekter Sturm: steigende Energiepreise, explodierende Produktionskosten und ein möglicher Super-El-Nino, der weltweit Ernten gefährdet. Erste Auswirkungen sind längst sichtbar – Weizen, Soja und Kakao verteuern sich deutlich, während Lebensmittelpreise vor dem nächsten Sprung stehen könnten.

Für Anleger bedeutet das nicht nur Risiken, sondern enorme Chancen. Denn während klassische Märkte unter Druck geraten könnten, entsteht auf den Feldern und Plantagen der nächste große Rohstoffzyklus. Wer sich jetzt richtig positioniert, kann von einer Entwicklung profitieren, die weit über Öl und Metalle hinausgeht.

In unserem aktuellen Spezialreport stellen wir drei Aktien vor, die besonders aussichtsreich sind, um von diesem Trend zu profitieren – solide positioniert, strategisch relevant und mit erheblichem Aufwärtspotenzial.



Jetzt den kostenlosen Report sichern – bevor der Agrar-Boom voll durchschlägt!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.